Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (921-930 of 1,203) with videos related to

Pageof 121
Sort By:
Cancer|August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Endocrinology|August 7, 2004
Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditureWing May Kong, Niamh M Martin, Kirsty L Smith, et al.
Diabetes|July 28, 2005
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trialKatie Wynne, Adrian J Park, Caroline J Small, et al.
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
Journal of the Academy of Nutrition and Dietetics|March 4, 2026
Managing nutrition after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): A qualitative study of colorectal cancer survivors' and caregivers' experiencesKea Turner, Amir Alishahi Tabriz, Ryan Chi-Hsuan Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2015
A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate CancerEric J Small, Raymond S Lance, Thomas A Gardner, et al.
Prostate Cancer|October 10, 2022
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate CancerRahul Aggarwal, Joshi J Alumkal, Russell Z Szmulewitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Pageof 121

Showing results (921-930 of 1,203) with videos related to

Sort By:
Pageof 121
Cancer|August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
Endocrinology|August 7, 2004
Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditureWing May Kong, Niamh M Martin, Kirsty L Smith, et al.
Diabetes|July 28, 2005
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trialKatie Wynne, Adrian J Park, Caroline J Small, et al.
The Journal of Urology|March 21, 2015
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched ComparisonBrian D Gonzalez, Heather S L Jim, Kristine A Donovan, et al.
Journal of the Academy of Nutrition and Dietetics|March 4, 2026
Managing nutrition after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): A qualitative study of colorectal cancer survivors' and caregivers' experiencesKea Turner, Amir Alishahi Tabriz, Ryan Chi-Hsuan Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2015
A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate CancerEric J Small, Raymond S Lance, Thomas A Gardner, et al.
Prostate Cancer|October 10, 2022
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate CancerRahul Aggarwal, Joshi J Alumkal, Russell Z Szmulewitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Pageof 121